Plasma homocysteine levels in patients with keratoconus
To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using...
Saved in:
Published in | Clinical and experimental optometry Vol. 103; no. 6; pp. 804 - 807 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Melbourne
Taylor & Francis
01.11.2020
Wiley Publishing Asia Pty Ltd Taylor & Francis Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 0816-4622 1444-0938 1444-0938 |
DOI | 10.1111/cxo.13044 |
Cover
Abstract | To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.
Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663-pg/mL, and 4.6-18.7-ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.
There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2-pg/ml in keratoconus patients versus 264.78 ± 94.2-pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2-ng/ml in keratoconus patients versus 6.72 ± 3.1-ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002).
The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking. |
---|---|
AbstractList | To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.
Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663 pg/mL, and 4.6-18.7 ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.
There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002).
The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking. To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.BACKGROUNDTo compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.Thirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663 pg/mL, and 4.6-18.7 ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.METHODSThirty-three keratoconus patients, and 47 age-gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191-663 pg/mL, and 4.6-18.7 ng/mL respectively. Mann-Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002).RESULTSThere was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim-K (p = 0.002).The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking.CONCLUSIONSThe increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co-factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking. Background To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Methods Thirty‐three keratoconus patients, and 47 age‐gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191–663 pg/mL, and 4.6–18.7 ng/mL respectively. Mann–Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively. Results There was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim‐K (p = 0.002). Conclusions The increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co‐factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking. BackgroundTo compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.MethodsThirty‐three keratoconus patients, and 47 age‐gender matched healthy subjects were included in this prospective study. The plasma level of homocysteine, folic acid, and vitamin B12 was assessed using the chemiluminescence immunometric method. According to the manufacturer's instructions, the normal plasma level of homocysteine, vitamin B12 and folic acid was accepted as ≤ 13 μm/L, 191–663 pg/mL, and 4.6–18.7 ng/mL respectively. Mann–Whitney U and Spearman's correlation tests were used for pairwise comparisons and correlation analysis, respectively.ResultsThere was a statistically significant difference between keratoconus patients and healthy subjects in terms of mean plasma level of homocysteine (15.02 ± 8.01 μm/l in keratoconus patients versus 12.62 ± 8.17 μm/l in healthy subjects, p = 0.01). However, the mean plasma level of either vitamin B12 (263.78 ± 107.2 pg/ml in keratoconus patients versus 264.78 ± 94.2 pg/ml in healthy subjects, p = 0.3), or folic acid (5.98 ± 3.2 ng/ml in keratoconus patients versus 6.72 ± 3.1 ng/ml in healthy subjects, p = 0.1) were not statistically significantly different between two groups. A negative correlation was found between plasma homocysteine level and central corneal thickness (p < 0.001). A positive correlation was found between plasma homocysteine level and steepest keratometry (p = 0.004) and average Sim‐K (p = 0.002).ConclusionsThe increased plasma level of homocysteine in keratoconus patients may either arise from a consequence of biochemical events such as oxidative stress, or it may contribute to the pathogenesis or progression of keratoconus by chelating copper, which is an important co‐factor of lysyl oxidase enzyme taking place in corneal collagen crosslinking. |
Author | Arikan, Sedat Yilmaz, Mehmet Türkön, Hakan |
Author_xml | – sequence: 1 givenname: Mehmet surname: Yilmaz fullname: Yilmaz, Mehmet organization: Ophthalmology Clinic, Hatay Antakya State Hospital – sequence: 2 givenname: Sedat surname: Arikan fullname: Arikan, Sedat organization: Department of Ophthalmology, Canakkale Onsekiz Mart University – sequence: 3 givenname: Hakan surname: Türkön fullname: Türkön, Hakan organization: Department of Medical Biochemistry, Canakkale Onsekiz Mart University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32036622$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kE1LXDEUhoMoOn4s-gfKhW50cTUf535kWQarBUEXCu5CbkwwNjeZJrmdzr9vdGY2VrM5EJ73PYfnEO364DVCXwg-J-VdqL_hnDAMsINmBABqzFm_i2a4J20NLaUH6DClF4wpMA776IBRzNryP0PdnZNplNVzGINapayt15XTf7RLlfXVQmarfU7V0ubn6peOMgcV_JSO0Z6RLumTzTxCDz8u7-fX9c3t1c_595taMd5DDbjrqOESsDENpZ3qYdC0xcMg8dAZ3uB26AhIAG4YsF5J3tBe94NUHA-EsCN0uu5dxPB70imL0SalnZNehykJyhqGCfTQFfTbO_QlTNGX6wSFBghvCIFCfd1Q0zDqJ7GIdpRxJbZKCnCxBlQMKUVthLK5aAg-R2mdIFi8ShdFuniTXhJn7xLb0o_YTfvSOr36HBTzx9ttAtYJ602Io1yG6J5ElisXoonSK5sE-3_RPwrYoHY |
CitedBy_id | crossref_primary_10_1097_j_jcrs_0000000000001160 crossref_primary_10_1111_aos_14714 crossref_primary_10_12998_wjcc_v12_i18_3378 crossref_primary_10_3390_ijms241310790 crossref_primary_10_3390_nu14040913 |
Cites_doi | 10.1097/IJG.0b013e31802d6942 10.1046/j.1442-9071.2001.d01-17.x 10.1046/j.1365-2362.2003.01189.x 10.1016/j.nbd.2006.06.010 10.1097/ICO.0b013e31822159f6 10.1371/journal.pone.0076333 10.1167/iovs.11-9268 10.1097/00003226-199403000-00003 10.3109/02713689209033483 10.3390/molecules21010012 10.1167/iovs.05-0828 10.1016/j.exer.2012.02.002 10.1167/iovs.14-14831 10.1111/j.1749-6632.1992.tb17100.x 10.1016/0026-0495(87)90043-6 10.1097/00003226-198803000-00001 10.1016/j.atherosclerosis.2004.06.015 10.1016/S0002-9394(02)02220-1 10.1167/iovs.08-2667 10.1007/s00702-013-0993-1 10.1016/j.exer.2012.09.005 10.1136/bjo.2008.144253 10.1159/000127832 10.1083/jcb.103.3.1121 10.1002/jcb.20137 10.1016/0003-9861(86)90105-0 |
ContentType | Journal Article |
Copyright | 2020 Optometry Australia 2020 2020 Optometry Australia 2020 Optometry Australia. |
Copyright_xml | – notice: 2020 Optometry Australia 2020 – notice: 2020 Optometry Australia – notice: 2020 Optometry Australia. |
DBID | AAYXX CITATION NPM 7TK NAPCQ 7X8 |
DOI | 10.1111/cxo.13044 |
DatabaseName | CrossRef PubMed Neurosciences Abstracts Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Nursing & Allied Health Premium Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic Nursing & Allied Health Premium |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1444-0938 |
EndPage | 807 |
ExternalDocumentID | 32036622 10_1111_cxo_13044 CXO13044 12124653 |
Genre | Original Article article Journal Article |
GrantInformation_xml | – fundername: Research Projects Commission of Canakkale Onsekiz Mart University funderid: TTU‐2016‐998 |
GroupedDBID | --- .3N .GA 05W 0BK 0R~ 10A 1OB 1OC 24P 29B 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AABVL AAESR AAEVG AAMIU AAONW AAPUL AAQRR AAWTL AAZKR ABBKH ABCQN ABCUV ABJNI ABLIJ ABPVW ABXYU ACENM ACGFO ACGFS ACIEZ ACMXC ACNCT ACPOU ACPRK ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADXAS ADZMN AEIMD AENEX AEUQT AFBPY AFGKR AFPWT AGFJD AGRBW AGYJP AIAGR AIRBT AIURR AJAOE AKBVH ALAGY ALMA_UNASSIGNED_HOLDINGS ALYBC AMBMR AMDAE AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BHBCM BMXJE BROTX BRXPI BY8 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EMB F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X H13 HZI HZ~ IX1 J0M K48 LATKE LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LYRES M4Z MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RNANH ROL RVRKI RX1 SUPJJ SV3 TBQAZ TDBHL TEORI TERGH TFL TR2 TUROJ UB1 UEQFS V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WQJ WRC WUP WVDHM WXI XG1 XSB ZZTAW ~IA ~WT .Y3 2WC 31~ AAHHS AANHP AAORF ABEML ABWCV ACBWZ ACCFJ ACKZS ACRPL ACSCC ACYXJ ADFOM ADNMO ADZOD AEEZP AEIIZ AEQDE AFLEI AFZJQ AGDLA AHEFC AIWBW AJBDE AJVHN ALQZU ASPBG AVWKF AZFZN BDRZF C1A CAG COF EJD FEDTE HF~ HVGLF KTM LW6 NUSFT PALCI RIWAO RJQFR WIN WOQ AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION NPM 7TK NAPCQ 7X8 |
ID | FETCH-LOGICAL-c3984-40772f9a40ff5227c84be260bba0b7f9506b714a449f3438ca9528e8bac90b113 |
IEDL.DBID | DR2 |
ISSN | 0816-4622 1444-0938 |
IngestDate | Thu Sep 04 16:58:35 EDT 2025 Fri Jul 25 07:20:24 EDT 2025 Wed Feb 19 02:29:03 EST 2025 Tue Jul 01 02:59:20 EDT 2025 Thu Apr 24 23:05:16 EDT 2025 Wed Jan 22 16:31:39 EST 2025 Wed Dec 25 09:08:01 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | homocysteine vitamin B12 keratoconus folic acid plasma |
Language | English |
License | 2020 Optometry Australia. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3984-40772f9a40ff5227c84be260bba0b7f9506b714a449f3438ca9528e8bac90b113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 32036622 |
PQID | 2454195114 |
PQPubID | 2045178 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_2353014847 wiley_primary_10_1111_cxo_13044_CXO13044 proquest_journals_2454195114 crossref_citationtrail_10_1111_cxo_13044 informaworld_taylorfrancis_310_1111_cxo_13044 pubmed_primary_32036622 crossref_primary_10_1111_cxo_13044 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 11/1/2020 November 2020 2020-11-01 2020-11-00 20201101 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: 11/1/2020 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Melbourne |
PublicationPlace_xml | – name: Melbourne – name: Australia – name: Chichester |
PublicationTitle | Clinical and experimental optometry |
PublicationTitleAlternate | Clin Exp Optom |
PublicationYear | 2020 |
Publisher | Taylor & Francis Wiley Publishing Asia Pty Ltd Taylor & Francis Ltd |
Publisher_xml | – name: Taylor & Francis – name: Wiley Publishing Asia Pty Ltd – name: Taylor & Francis Ltd |
References | 1987; 36 2015; 56 2013; 4 2013; 120 2001; 29 2013; 7 2012; 104 1992; 11 2003; 135 2014; 130 2012; 31 2012; 53 2003; 33 2001; 42 1992; 30 2007; 16 2004; 177 1986; 103 2004; 93 2006; 23 1986; 244 2009; 50 2009; 93 2006; 47 1988; 7 2015; 21 1997; 38 1994; 13 2008; 40 Kolozsvari BL (CIT0019) 2013; 4 CIT0030 Raposo B (CIT0010) 2004; 177 Roedl JB (CIT0029) 2008; 40 Smolek MK (CIT0002) 1997; 38 CIT0014 Coral K (CIT0020) 2009; 50 CIT0016 CIT0015 CIT0018 CIT0017 Vazirani J (CIT0001) 2013; 7 Holven KB (CIT0024) 2003; 33 CIT0021 CIT0023 Kang SS (CIT0012) 1987; 36 Avetisov SE (CIT0013) 2014; 130 Mason JB (CIT0011) 1992; 30 CIT0003 Sethi A (CIT0022) 2012; 104 CIT0025 Behndig A (CIT0028) 2001; 42 CIT0005 CIT0027 CIT0004 CIT0026 CIT0007 CIT0006 CIT0009 CIT0008 |
References_xml | – volume: 31 start-page: 227 year: 2012 end-page: 231 article-title: Riboflavin‐UVA‐induced corneal collagen cross‐linking in pediatric patients publication-title: Cornea – volume: 29 start-page: 340 year: 2001 end-page: 344 article-title: Is the corneal degradation in keratoconus caused by matrix‐metalloproteinases? publication-title: Clin Exp Ophthalmol – volume: 56 start-page: 738 year: 2015 end-page: 750 article-title: Elevated expression of matrix metalloproteinase‐9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A publication-title: Invest Ophthalmol Vis Sci – volume: 7 start-page: 163 year: 1988 end-page: 169 article-title: Keratoconus publication-title: Cornea – volume: 36 start-page: 458 year: 1987 end-page: 462 article-title: Homocysteinemia due to folate deficiency publication-title: Metabolism – volume: 93 start-page: 207 year: 2004 end-page: 213 article-title: Homocysteine induces metalloproteinase and shedding of beta‐1 integrin in microvessel endothelial cells publication-title: J Cell Biochem – volume: 16 start-page: 234 year: 2007 end-page: 239 article-title: Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma publication-title: J Glaucoma – volume: 120 start-page: 977 year: 2013 end-page: 982 article-title: The impairment of lysyl oxidase in keratoconus and in keratoconus‐associated disorders publication-title: J Neural Transm – volume: 23 start-page: 725 year: 2006 end-page: 730 article-title: Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY‐5Y cells publication-title: Neurobiol Dis – volume: 42 start-page: 2293 year: 2001 end-page: 2296 article-title: Superoxide dismutase isoenzymes in the normal and diseased human cornea publication-title: Invest Ophthalmol Vis Sci – volume: 38 start-page: 1289 year: 1997 end-page: 1290 article-title: Collagen fibril orientation in the human corneal stroma and its implications in keratoconus publication-title: Invest Ophthalmol Vis Sci – volume: 104 start-page: 74 year: 2012 end-page: 81 article-title: Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas publication-title: Exp Eye Res – volume: 103 start-page: 1121 year: 1986 end-page: 1128 article-title: Ultrastructural immunolocalization of lysyl oxidase in vascular connective tissue publication-title: J Cell Biol – volume: 33 start-page: 555 year: 2003 end-page: 560 article-title: Expression of matrix metalloproteinase‐9 in mononuclear cells of hyperhomocysteinaemic subjects publication-title: Eur J Clin Invest – volume: 93 start-page: 820 year: 2009 end-page: 824 article-title: Subclinical keratoconus and inflammatory molecules from tears publication-title: Br J Ophthalmol – volume: 104 start-page: 97 year: 2012 end-page: 98 article-title: Focus on molecules: lysyl oxidase publication-title: Exp Eye Res – volume: 7 start-page: 2019 year: 2013 end-page: 2030 article-title: Keratoconus: current perspectives publication-title: Clin Ophthalmol – volume: 4 year: 2013 article-title: Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes publication-title: PLoS One – volume: 47 start-page: 1902 year: 2006 end-page: 1910 article-title: Increased stress‐induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts publication-title: Invest Ophthalmol Vis Sci – volume: 177 start-page: 1 year: 2004 end-page: 8 article-title: High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells publication-title: Atherosclerosis – volume: 30 start-page: 197 year: 1992 end-page: 203 article-title: The effects of vitamins B12, B6, and folate on blood homocysteine levels publication-title: Ann N Y Acad Sci – volume: 244 start-page: 161 year: 1986 end-page: 168 article-title: Role of plasma and serum proteases in the degradation of elastin publication-title: Arch Biochem Biophys – volume: 21 start-page: 12 year: 2015 end-page: 25 article-title: Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity publication-title: Mol Vis – volume: 13 start-page: 114 year: 1994 end-page: 124 article-title: Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase‐2/tissue inhibitor of metalloproteinase ratio publication-title: Cornea – volume: 135 start-page: 620 year: 2003 end-page: 627 article-title: Riboflavin/ultraviolet‐A‐induced collagen crosslinking for the treatment of keratoconus publication-title: Am J Ophthalmol – volume: 40 start-page: 249 year: 2008 end-page: 256 article-title: Increased homocysteine levels in tear fluid of patients with primary open‐angle glaucoma publication-title: Ophthalmic Res – volume: 130 start-page: 110 year: 2014 end-page: 116 article-title: Keratoconus: etiological factors and accompanying manifestations publication-title: Vestn Oftalmol – volume: 50 start-page: 3607 year: 2009 end-page: 3612 article-title: Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase publication-title: Invest Ophthalmol Vis Sci – volume: 53 start-page: 4152 year: 2012 end-page: 4157 article-title: Variation in the lysyl oxidase (LOX) gene is associated with keratoconus in family‐based and case‐control studies publication-title: Invest Ophthalmol Vis Sci – volume: 11 start-page: 849 year: 1992 end-page: 862 article-title: Collagenolytic/gelatinolytic mettaloproteinases in normal and keratoconus corneas publication-title: Curr Eye Res – ident: CIT0030 doi: 10.1097/IJG.0b013e31802d6942 – ident: CIT0017 doi: 10.1046/j.1442-9071.2001.d01-17.x – volume: 33 start-page: 555 year: 2003 ident: CIT0024 publication-title: Eur J Clin Invest doi: 10.1046/j.1365-2362.2003.01189.x – ident: CIT0021 doi: 10.1016/j.nbd.2006.06.010 – ident: CIT0007 doi: 10.1097/ICO.0b013e31822159f6 – volume: 130 start-page: 110 year: 2014 ident: CIT0013 publication-title: Vestn Oftalmol – volume: 4 start-page: e76333 year: 2013 ident: CIT0019 publication-title: PLoS One doi: 10.1371/journal.pone.0076333 – ident: CIT0015 doi: 10.1167/iovs.11-9268 – ident: CIT0004 doi: 10.1097/00003226-199403000-00003 – volume: 42 start-page: 2293 year: 2001 ident: CIT0028 publication-title: Invest Ophthalmol Vis Sci – ident: CIT0003 doi: 10.3109/02713689209033483 – ident: CIT0016 doi: 10.3390/molecules21010012 – ident: CIT0027 doi: 10.1167/iovs.05-0828 – volume: 104 start-page: 97 year: 2012 ident: CIT0022 publication-title: Exp Eye Res doi: 10.1016/j.exer.2012.02.002 – ident: CIT0026 doi: 10.1167/iovs.14-14831 – volume: 30 start-page: 197 year: 1992 ident: CIT0011 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1992.tb17100.x – volume: 36 start-page: 458 year: 1987 ident: CIT0012 publication-title: Metabolism doi: 10.1016/0026-0495(87)90043-6 – ident: CIT0005 doi: 10.1097/00003226-198803000-00001 – volume: 177 start-page: 1 year: 2004 ident: CIT0010 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2004.06.015 – volume: 38 start-page: 1289 year: 1997 ident: CIT0002 publication-title: Invest Ophthalmol Vis Sci – ident: CIT0006 doi: 10.1016/S0002-9394(02)02220-1 – volume: 50 start-page: 3607 year: 2009 ident: CIT0020 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-2667 – ident: CIT0009 doi: 10.1007/s00702-013-0993-1 – ident: CIT0014 doi: 10.1016/j.exer.2012.09.005 – ident: CIT0025 doi: 10.1136/bjo.2008.144253 – volume: 7 start-page: 2019 year: 2013 ident: CIT0001 publication-title: Clin Ophthalmol – volume: 40 start-page: 249 year: 2008 ident: CIT0029 publication-title: Ophthalmic Res doi: 10.1159/000127832 – ident: CIT0008 doi: 10.1083/jcb.103.3.1121 – ident: CIT0023 doi: 10.1002/jcb.20137 – ident: CIT0018 doi: 10.1016/0003-9861(86)90105-0 |
SSID | ssj0024394 |
Score | 2.249375 |
Snippet | To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.
Thirty-three keratoconus patients, and 47 age-gender... Background To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects. Methods Thirty‐three keratoconus patients, and... BackgroundTo compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.MethodsThirty‐three keratoconus patients, and 47... To compare the plasma levels of homocysteine between patients with keratoconus and healthy subjects.BACKGROUNDTo compare the plasma levels of homocysteine... |
SourceID | proquest pubmed crossref wiley informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 804 |
SubjectTerms | Chemiluminescence Collagen Cornea Correlation analysis Folic acid Homocysteine Keratoconus Lysyl oxidase Oxidative stress Plasma Plasma levels Statistical analysis Vitamin B Vitamin B12 |
Title | Plasma homocysteine levels in patients with keratoconus |
URI | https://www.tandfonline.com/doi/abs/10.1111/cxo.13044 https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcxo.13044 https://www.ncbi.nlm.nih.gov/pubmed/32036622 https://www.proquest.com/docview/2454195114 https://www.proquest.com/docview/2353014847 |
Volume | 103 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7LHsSL78f6oooHL12aNmkbPMnqsgg-EIU9CCXJpihqK3YXxF_vTPpgV1YQb6WZwiSZ6XyTxzeEHKecphCIqcsjNnKZjJgrtPFcw7mOIYIJY7k7r67DwQO7HPJhi5zWd2FKfohmwQ09w_6v0cGlKqacXH_mWMqYIRcoDULkzT-_86d49mwRRKwr4bLQ9ytWITzF03w5E4tmmErn4c1Z-GrjT3-ZPNaal8dOXrqTserqrx-kjv_s2gpZqnCpc1Ya0ippmWyNLFxVO-_rJLoFmP0mnaf8LdfI_gxvnVc8cVQ4z5lT0bMWDq7rOi_I1JxDpj0pNshD_-K-N3CroguuDkTMIJ8EvJ0Kybw0BWwW6ZgpA0mPUtJTUSq4F6qIMsmYSAMWxFoK7scmVlILT1EabJJ2lmdmmzjUiJHmjI6Ql80zoeBxGIfUhJ5U1NesQ07q4U90xUiOhTFekzozgYFI7EB0yFEj-l7ScMwTcqfnMBnbNY-0LFCSBHPk9-pJTirPLRKfgcYAOyk0HzbN4HO4kSIzk09AJuCYiUJg75Ct0jgarQLc2QV7g87ZKf5d3aQ3vLEPO38X3SWLPib89jLkHmmPPyZmH1DRWB1Y8_8GUk8FYA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qBfWl9duzVaP44EtKNplNsuCLVMupvSrSwr3Isru3QWmbiHcHxb_emc0Hd3KC-BayE5j9mMxvZnd_A_CykqIiRyxiWeAsRlNgrJxPYi-lK8mDKR-4Oycn-fgMP0zldAte93dhWn6IIeHGlhH-12zgnJBesXJ31XAtY8RrcB0JaHDo9fZLusK0F8ogcmWJGPM07XiF-BzP8OmaN1rjKt2EONcBbPBAR7vwtde9PXhyfrBc2AP36w9ax__t3G3Y6aBp9KZdS3dgy9d34cak23y_B8VnQtqXJvrWXDaOCaDpbXTBh47m0fc66hha5xGndqNzJmtuKNhezu_D2dG708Nx3NVdiF2mSqSQkiB3pQwmVUXwrHAlWk9xj7UmsUWlZJLbQqBBVFWGWemMkmnpS2ucSqwQ2QPYrpvaP4JIeDVzEsWMqdkSnytZ5mUufJ4YK1KHI3jVj792HSk518a40H1wQgOhw0CM4MUg-qNl4tgkFK9Ool6EtEfV1ijR2Qb5_X6WdWe8c50iaUzIU1Dz86GZzI73UkztmyXJZJKDUfLtI3jYro5Bq4w3d2nBUefCHP9dXX04_RQeHv-76DO4OT6dHOvj9ycf9-BWyvF_uBu5D9uLn0v_hEDSwj4NtvAbrY4Jfw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SBEIvefSVTdLWLT304mDZI9uip5J0SR9JQ2lgDwUhaSUaktghuwshvz4j-cFu2ULpzVhjGI00nm_0-AbgnePMUSBmMS9wHKMqMBbGJrHl3JQUwYQN3J0np_nxOX4Z8dEKfOjuwjT8EP2Cm_eM8L_2Dn4zdnNObu5qX8oY8RGsYU5IwiOiH-kc0V6ogugLS8SYp2lLK-SP8fSfLgSjBarSZYBzEb-GADTchF-d6s25k8uD2VQfmPs_WB3_s29bsNEC0-hjM5O2YcVWT2D9pN16fwrFGeHsaxX9rq9r4-mf6W105Y8cTaKLKmr5WSeRX9iNLj1Vc02p9mzyDM6Hn34eHsdt1YXYZKJESigJcDuhMHGOwFlhStSWsh6tVaILJ3iS64KhQhQuw6w0SvC0tKVWRiSasew5rFZ1ZXcgYlaMDUc29sRsic0FL_MyZzZPlGapwQG878wvTUtJ7itjXMkuNSFDyGCIAbztRW8aHo5lQvH8GMppWPRwTYUSmS2R3-8GWbauO5EpksaEOxk1v-mbyen8ToqqbD0jmYz7VJQi-wBeNJOj1yrzW7s036hzYYj_rq48HH0PD7v_Lvoa1s-OhvLb59Ove_A49cl_uBi5D6vT25l9SQhpql8FT3gAiZoILg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+homocysteine+levels+in+patients+with+keratoconus&rft.jtitle=Clinical+and+experimental+optometry&rft.au=Yilmaz%2C+Mehmet&rft.au=Arikan%2C+Sedat&rft.au=T%C3%BCrk%C3%B6n%2C+Hakan&rft.date=2020-11-01&rft.eissn=1444-0938&rft.volume=103&rft.issue=6&rft.spage=804&rft_id=info:doi/10.1111%2Fcxo.13044&rft_id=info%3Apmid%2F32036622&rft.externalDocID=32036622 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0816-4622&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0816-4622&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0816-4622&client=summon |